Table 1.
Clinical-pathological Features | STK32C |
P value | |||
---|---|---|---|---|---|
High | Low | Total | |||
Age | ≥ 70 | 24 | 18 | 42 | 0.001* |
< 70 | 13 | 41 | 54 | ||
Sex | Male | 26 | 53 | 79 | 0.015* |
Female | 11 | 6 | 17 | ||
Smoking | YES | 19 | 23 | 42 | 0.234 |
NO | 18 | 36 | 54 | ||
Tumor number | 1 | 14 | 36 | 50 | 0.027* |
≥ 2 | 23 | 23 | 46 | ||
Tumor size | < 2 | 7 | 26 | 33 | 0.012* |
≥ 2 | 30 | 33 | 63 | ||
Grade | Low | 11 | 20 | 31 | 0.671 |
High | 26 | 39 | 65 | ||
pT stage | Ta, T1 | 14 | 38 | 52 | 0.011* |
T2, T3, T4 | 23 | 21 | 44 | ||
Recurrence† | YES | 15 | 20 | 35 | 0.028* |
NO | 5 | 24 | 29 |
“*”, represents a significant association; P < 0.05 for the difference was significant.
“†”, Recurrence of bladder cancer patients only included patients treated by TURBT.